Sevenfact
Payments companies reported to CMS as associated with Sevenfact. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sevenfact, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sevenfact
These are the largest totals companies reported as associated with Sevenfact. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Guy Young | Bozeman, MT | Pediatric Hematology-Oncology | $156,952.92 |
| Doris Quon | Los Angeles, CA | Hematology (Internal Medicine) | $130,522.14 |
| Tammuella Chrisentery-Singleton | New Orleans, LA | Pediatric Hematology-Oncology | $106,793.93 |
| Miguel Escobar | Houston, TX | Hematology (Internal Medicine) | $95,902.77 |
| Steven Pipe | Ann Arbor, MI | Pediatric Hematology-Oncology | $93,210.73 |
| Robert Sidonio | Atlanta, GA | Pediatric Hematology-Oncology | $58,725.84 |
| Amy Dunn | Columbus, OH | Pediatric Hematology-Oncology | $41,227.17 |
| Maissaa Janbain | New Orleans, LA | Hematology & Oncology | $40,348.09 |
| Adam Giermasz | Sacramento, CA | Hematology & Oncology | $39,414.24 |
| Mark Reding | Minneapolis, MN | Hematology & Oncology | $31,017.30 |
Prescribed Sevenfact?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.